nodes	percent_of_prediction	percent_of_DWPC	metapath
Liothyronine—THRB—breast cancer	0.177	0.554	CbGaD
Liothyronine—SLC7A5—Melphalan—breast cancer	0.156	0.515	CbGbCtD
Liothyronine—L-Tyrosine—Melphalan—breast cancer	0.11	0.469	CrCrCtD
Liothyronine—SLCO1B1—breast cancer	0.104	0.325	CbGaD
Liothyronine—L-DOPA—Melphalan—breast cancer	0.0778	0.332	CrCrCtD
Liothyronine—L-Phenylalanine—Melphalan—breast cancer	0.0466	0.199	CrCrCtD
Liothyronine—SLCO1A2—Chlorambucil—breast cancer	0.0235	0.0779	CbGbCtD
Liothyronine—ALB—breast cancer	0.0197	0.0617	CbGaD
Liothyronine—ABCB1—breast cancer	0.0188	0.0589	CbGaD
Liothyronine—SLCO4C1—Methotrexate—breast cancer	0.0174	0.0576	CbGbCtD
Liothyronine—SLCO1B3—Paclitaxel—breast cancer	0.0131	0.0433	CbGbCtD
Liothyronine—SLCO1C1—Methotrexate—breast cancer	0.0122	0.0405	CbGbCtD
Liothyronine—SLCO1B3—Docetaxel—breast cancer	0.00946	0.0313	CbGbCtD
Liothyronine—ABCB1—Toremifene—breast cancer	0.00768	0.0254	CbGbCtD
Liothyronine—SLCO1B1—Irinotecan—breast cancer	0.00752	0.0249	CbGbCtD
Liothyronine—SLCO1B3—Methotrexate—breast cancer	0.00683	0.0226	CbGbCtD
Liothyronine—ABCB1—Lapatinib—breast cancer	0.0056	0.0185	CbGbCtD
Liothyronine—SLCO1A2—Methotrexate—breast cancer	0.00422	0.0139	CbGbCtD
Liothyronine—ALB—Irinotecan—breast cancer	0.00412	0.0136	CbGbCtD
Liothyronine—SLCO1B1—Methotrexate—breast cancer	0.00398	0.0132	CbGbCtD
Liothyronine—ALB—Fluorouracil—breast cancer	0.00395	0.0131	CbGbCtD
Liothyronine—SLC22A8—Methotrexate—breast cancer	0.00367	0.0121	CbGbCtD
Liothyronine—ABCB1—Vinorelbine—breast cancer	0.00311	0.0103	CbGbCtD
Liothyronine—ABCB1—Tamoxifen—breast cancer	0.0028	0.00928	CbGbCtD
Liothyronine—ABCB1—Mitoxantrone—breast cancer	0.00273	0.00905	CbGbCtD
Liothyronine—ABCB1—Gemcitabine—breast cancer	0.00242	0.00799	CbGbCtD
Liothyronine—ABCB1—Paclitaxel—breast cancer	0.00218	0.00722	CbGbCtD
Liothyronine—ALB—Methotrexate—breast cancer	0.00218	0.00721	CbGbCtD
Liothyronine—ABCB1—Irinotecan—breast cancer	0.00215	0.00712	CbGbCtD
Liothyronine—ABCB1—Vinblastine—breast cancer	0.00191	0.00633	CbGbCtD
Liothyronine—ABCB1—Docetaxel—breast cancer	0.00158	0.00522	CbGbCtD
Liothyronine—ABCB1—Doxorubicin—breast cancer	0.00118	0.00389	CbGbCtD
Liothyronine—THRB—mammary gland—breast cancer	0.00116	0.0381	CbGeAlD
Liothyronine—ABCB1—Methotrexate—breast cancer	0.00114	0.00377	CbGbCtD
Liothyronine—Phlebitis—Carboplatin—breast cancer	0.00107	0.0282	CcSEcCtD
Liothyronine—SLCO4C1—nipple—breast cancer	0.000999	0.0329	CbGeAlD
Liothyronine—SLC7A5—mammary gland—breast cancer	0.000884	0.0291	CbGeAlD
Liothyronine—SLCO4A1—mammary gland—breast cancer	0.000772	0.0254	CbGeAlD
Liothyronine—SERPINA7—bone marrow—breast cancer	0.000732	0.0241	CbGeAlD
Liothyronine—SLC7A5—nipple—breast cancer	0.000731	0.0241	CbGeAlD
Liothyronine—Phlebitis—Letrozole—breast cancer	0.000715	0.0188	CcSEcCtD
Liothyronine—SLCO1B1—mammary gland—breast cancer	0.000679	0.0224	CbGeAlD
Liothyronine—Phlebitis—Idarubicin—breast cancer	0.000678	0.0179	CcSEcCtD
Liothyronine—Muscle twitching—Chlorambucil—breast cancer	0.000664	0.0175	CcSEcCtD
Liothyronine—SLC7A5—Desoximetasone—Fluoxymesterone—breast cancer	0.000663	1	CbGdCrCtD
Liothyronine—Angina pectoris—Toremifene—breast cancer	0.000663	0.0175	CcSEcCtD
Liothyronine—SERPINA7—endocrine gland—breast cancer	0.000656	0.0216	CbGeAlD
Liothyronine—Dextrothyroxine—THRB—breast cancer	0.000648	0.225	CrCbGaD
Liothyronine—Cardiac failure congestive—Idarubicin—breast cancer	0.000644	0.017	CcSEcCtD
Liothyronine—SLCO4A1—nipple—breast cancer	0.000638	0.021	CbGeAlD
Liothyronine—SLCO4C1—endometrium—breast cancer	0.000603	0.0199	CbGeAlD
Liothyronine—Acute coronary syndrome—Toremifene—breast cancer	0.000598	0.0158	CcSEcCtD
Liothyronine—Myocardial infarction—Toremifene—breast cancer	0.000595	0.0157	CcSEcCtD
Liothyronine—TTR—embryo—breast cancer	0.000588	0.0193	CbGeAlD
Liothyronine—Angina pectoris—Exemestane—breast cancer	0.000583	0.0154	CcSEcCtD
Liothyronine—SLC16A10—nipple—breast cancer	0.00056	0.0184	CbGeAlD
Liothyronine—Angina pectoris—Ixabepilone—breast cancer	0.000551	0.0145	CcSEcCtD
Liothyronine—ALB—mammary gland—breast cancer	0.000549	0.0181	CbGeAlD
Liothyronine—SLCO1B3—pituitary gland—breast cancer	0.000531	0.0175	CbGeAlD
Liothyronine—Acute coronary syndrome—Exemestane—breast cancer	0.000526	0.0139	CcSEcCtD
Liothyronine—THRB—pituitary gland—breast cancer	0.000524	0.0172	CbGeAlD
Liothyronine—Myocardial infarction—Exemestane—breast cancer	0.000523	0.0138	CcSEcCtD
Liothyronine—THRA—adipose tissue—breast cancer	0.000521	0.0172	CbGeAlD
Liothyronine—THRB—adipose tissue—breast cancer	0.000521	0.0172	CbGeAlD
Liothyronine—Angina pectoris—Anastrozole—breast cancer	0.000518	0.0137	CcSEcCtD
Liothyronine—Angina pectoris—Letrozole—breast cancer	0.000518	0.0137	CcSEcCtD
Liothyronine—Phlebitis—Vinblastine—breast cancer	0.000503	0.0133	CcSEcCtD
Liothyronine—Acute coronary syndrome—Ixabepilone—breast cancer	0.000497	0.0131	CcSEcCtD
Liothyronine—Myocardial infarction—Ixabepilone—breast cancer	0.000494	0.013	CcSEcCtD
Liothyronine—SLC7A5—epithelium—breast cancer	0.000492	0.0162	CbGeAlD
Liothyronine—Levothyroxine—THRB—breast cancer	0.000491	0.171	CrCbGaD
Liothyronine—Arrhythmia—Toremifene—breast cancer	0.000487	0.0128	CcSEcCtD
Liothyronine—Liotrix—THRB—breast cancer	0.000479	0.166	CrCbGaD
Liothyronine—THRB—female reproductive system—breast cancer	0.000479	0.0158	CbGeAlD
Liothyronine—THRA—female reproductive system—breast cancer	0.000479	0.0158	CbGeAlD
Liothyronine—SLCO4C1—bone marrow—breast cancer	0.000472	0.0155	CbGeAlD
Liothyronine—SLC7A5—skin of body—breast cancer	0.000468	0.0154	CbGeAlD
Liothyronine—Acute coronary syndrome—Anastrozole—breast cancer	0.000468	0.0123	CcSEcCtD
Liothyronine—Acute coronary syndrome—Letrozole—breast cancer	0.000468	0.0123	CcSEcCtD
Liothyronine—THRB—adrenal gland—breast cancer	0.000468	0.0154	CbGeAlD
Liothyronine—THRA—adrenal gland—breast cancer	0.000468	0.0154	CbGeAlD
Liothyronine—Myocardial infarction—Anastrozole—breast cancer	0.000465	0.0123	CcSEcCtD
Liothyronine—Myocardial infarction—Letrozole—breast cancer	0.000465	0.0123	CcSEcCtD
Liothyronine—Acute coronary syndrome—Idarubicin—breast cancer	0.000444	0.0117	CcSEcCtD
Liothyronine—Cardiac failure congestive—Goserelin—breast cancer	0.000444	0.0117	CcSEcCtD
Liothyronine—Myocardial infarction—Idarubicin—breast cancer	0.000441	0.0116	CcSEcCtD
Liothyronine—SLC7A5—endometrium—breast cancer	0.000441	0.0145	CbGeAlD
Liothyronine—THRA—female gonad—breast cancer	0.000436	0.0144	CbGeAlD
Liothyronine—THRB—female gonad—breast cancer	0.000436	0.0144	CbGeAlD
Liothyronine—SLCO1C1—pituitary gland—breast cancer	0.000435	0.0143	CbGeAlD
Liothyronine—SLCO1C1—adipose tissue—breast cancer	0.000433	0.0143	CbGeAlD
Liothyronine—SLC10A1—female reproductive system—breast cancer	0.000424	0.014	CbGeAlD
Liothyronine—Phlebitis—Vinorelbine—breast cancer	0.000418	0.011	CcSEcCtD
Liothyronine—SLCO1B3—endocrine gland—breast cancer	0.000411	0.0135	CbGeAlD
Liothyronine—SLC7A5—uterus—breast cancer	0.000407	0.0134	CbGeAlD
Liothyronine—THRB—endocrine gland—breast cancer	0.000406	0.0134	CbGeAlD
Liothyronine—THRA—endocrine gland—breast cancer	0.000406	0.0134	CbGeAlD
Liothyronine—SLC7A5—pituitary gland—breast cancer	0.000399	0.0131	CbGeAlD
Liothyronine—SLC7A5—adipose tissue—breast cancer	0.000398	0.0131	CbGeAlD
Liothyronine—TTR—pituitary gland—breast cancer	0.000389	0.0128	CbGeAlD
Liothyronine—SLCO4A1—endometrium—breast cancer	0.000385	0.0127	CbGeAlD
Liothyronine—Dextrothyroxine—SLCO1B1—breast cancer	0.00038	0.132	CrCbGaD
Liothyronine—SLC16A10—epithelium—breast cancer	0.000377	0.0124	CbGeAlD
Liothyronine—SLC7A5—female reproductive system—breast cancer	0.000366	0.012	CbGeAlD
Liothyronine—Angina pectoris—Vinblastine—breast cancer	0.000365	0.00963	CcSEcCtD
Liothyronine—Arrhythmia—Idarubicin—breast cancer	0.000361	0.00952	CcSEcCtD
Liothyronine—Hypertension—Exemestane—breast cancer	0.00036	0.0095	CcSEcCtD
Liothyronine—SLC10A1—endocrine gland—breast cancer	0.000359	0.0118	CbGeAlD
Liothyronine—Body temperature increased—Carboplatin—breast cancer	0.000358	0.00943	CcSEcCtD
Liothyronine—SLC7A5—adrenal gland—breast cancer	0.000357	0.0117	CbGeAlD
Liothyronine—TTR—female reproductive system—breast cancer	0.000356	0.0117	CbGeAlD
Liothyronine—Angina pectoris—Tamoxifen—breast cancer	0.000355	0.00935	CcSEcCtD
Liothyronine—SLCO4A1—pituitary gland—breast cancer	0.000349	0.0115	CbGeAlD
Liothyronine—SLCO4A1—adipose tissue—breast cancer	0.000347	0.0114	CbGeAlD
Liothyronine—SLC7A5—bone marrow—breast cancer	0.000345	0.0114	CbGeAlD
Liothyronine—Phlebitis—Mitoxantrone—breast cancer	0.000345	0.0091	CcSEcCtD
Liothyronine—Angina pectoris—Goserelin—breast cancer	0.000339	0.00893	CcSEcCtD
Liothyronine—SLCO1C1—endocrine gland—breast cancer	0.000337	0.0111	CbGeAlD
Liothyronine—TTR—bone marrow—breast cancer	0.000336	0.0111	CbGeAlD
Liothyronine—SLC7A5—female gonad—breast cancer	0.000333	0.011	CbGeAlD
Liothyronine—Acute coronary syndrome—Vinblastine—breast cancer	0.000329	0.00869	CcSEcCtD
Liothyronine—Cardiac failure congestive—Mitoxantrone—breast cancer	0.000328	0.00864	CcSEcCtD
Liothyronine—Myocardial infarction—Vinblastine—breast cancer	0.000328	0.00864	CcSEcCtD
Liothyronine—Hypertension—Anastrozole—breast cancer	0.00032	0.00844	CcSEcCtD
Liothyronine—Hypertension—Letrozole—breast cancer	0.00032	0.00844	CcSEcCtD
Liothyronine—Acute coronary syndrome—Tamoxifen—breast cancer	0.00032	0.00844	CcSEcCtD
Liothyronine—Cardiac failure congestive—Gemcitabine—breast cancer	0.000319	0.00842	CcSEcCtD
Liothyronine—SLCO4A1—female reproductive system—breast cancer	0.000319	0.0105	CbGeAlD
Liothyronine—Myocardial infarction—Tamoxifen—breast cancer	0.000318	0.00839	CcSEcCtD
Liothyronine—SLCO4A1—adrenal gland—breast cancer	0.000312	0.0103	CbGeAlD
Liothyronine—Body temperature increased—Fulvestrant—breast cancer	0.00031	0.00817	CcSEcCtD
Liothyronine—SLC7A5—endocrine gland—breast cancer	0.000309	0.0102	CbGeAlD
Liothyronine—Acute coronary syndrome—Goserelin—breast cancer	0.000306	0.00806	CcSEcCtD
Liothyronine—SLC16A10—adipose tissue—breast cancer	0.000305	0.01	CbGeAlD
Liothyronine—Myocardial infarction—Goserelin—breast cancer	0.000304	0.00802	CcSEcCtD
Liothyronine—Angina pectoris—Vinorelbine—breast cancer	0.000303	0.008	CcSEcCtD
Liothyronine—TTR—endocrine gland—breast cancer	0.000301	0.00992	CbGeAlD
Liothyronine—Hypotension—Ixabepilone—breast cancer	0.0003	0.00792	CcSEcCtD
Liothyronine—Tachycardia—Letrozole—breast cancer	0.000295	0.00779	CcSEcCtD
Liothyronine—Levothyroxine—SLCO1B1—breast cancer	0.000288	0.1	CrCbGaD
Liothyronine—Phlebitis—Paclitaxel—breast cancer	0.000281	0.00742	CcSEcCtD
Liothyronine—Liotrix—SLCO1B1—breast cancer	0.000281	0.0976	CrCbGaD
Liothyronine—SLCO1B1—female reproductive system—breast cancer	0.000281	0.00925	CbGeAlD
Liothyronine—THRB—lymph node—breast cancer	0.00028	0.00923	CbGeAlD
Liothyronine—THRA—lymph node—breast cancer	0.00028	0.00923	CbGeAlD
Liothyronine—SLC16A10—female reproductive system—breast cancer	0.00028	0.00922	CbGeAlD
Liothyronine—Acute coronary syndrome—Vinorelbine—breast cancer	0.000274	0.00722	CcSEcCtD
Liothyronine—Myocardial infarction—Vinorelbine—breast cancer	0.000272	0.00718	CcSEcCtD
Liothyronine—SLCO4A1—endocrine gland—breast cancer	0.00027	0.0089	CbGeAlD
Liothyronine—Body temperature increased—Exemestane—breast cancer	0.000269	0.0071	CcSEcCtD
Liothyronine—Cardiac failure congestive—Paclitaxel—breast cancer	0.000267	0.00705	CcSEcCtD
Liothyronine—Arrhythmia—Tamoxifen—breast cancer	0.00026	0.00687	CcSEcCtD
Liothyronine—Arrhythmia—Melphalan—breast cancer	0.000255	0.00672	CcSEcCtD
Liothyronine—Body temperature increased—Ixabepilone—breast cancer	0.000254	0.0067	CcSEcCtD
Liothyronine—Angina pectoris—Irinotecan—breast cancer	0.00025	0.0066	CcSEcCtD
Liothyronine—Arrhythmia—Goserelin—breast cancer	0.000249	0.00656	CcSEcCtD
Liothyronine—Angina pectoris—Fluorouracil—breast cancer	0.00024	0.00632	CcSEcCtD
Liothyronine—Body temperature increased—Anastrozole—breast cancer	0.000239	0.00631	CcSEcCtD
Liothyronine—Body temperature increased—Letrozole—breast cancer	0.000239	0.00631	CcSEcCtD
Liothyronine—Phlebitis—Docetaxel—breast cancer	0.000239	0.00629	CcSEcCtD
Liothyronine—SLCO1B1—endocrine gland—breast cancer	0.000238	0.00783	CbGeAlD
Liothyronine—SLC16A10—endocrine gland—breast cancer	0.000237	0.0078	CbGeAlD
Liothyronine—SLCO1C1—lymph node—breast cancer	0.000233	0.00767	CbGeAlD
Liothyronine—Phlebitis—Capecitabine—breast cancer	0.000231	0.00609	CcSEcCtD
Liothyronine—Body temperature increased—Idarubicin—breast cancer	0.000227	0.00599	CcSEcCtD
Liothyronine—Body temperature increased—Raloxifene—breast cancer	0.000227	0.00599	CcSEcCtD
Liothyronine—Cardiac failure congestive—Docetaxel—breast cancer	0.000227	0.00598	CcSEcCtD
Liothyronine—Acute coronary syndrome—Irinotecan—breast cancer	0.000226	0.00596	CcSEcCtD
Liothyronine—Acute coronary syndrome—Mitoxantrone—breast cancer	0.000226	0.00596	CcSEcCtD
Liothyronine—Hypertension—Vinblastine—breast cancer	0.000226	0.00595	CcSEcCtD
Liothyronine—Myocardial infarction—Irinotecan—breast cancer	0.000225	0.00592	CcSEcCtD
Liothyronine—Myocardial infarction—Mitoxantrone—breast cancer	0.000225	0.00592	CcSEcCtD
Liothyronine—Arrhythmia—Vinorelbine—breast cancer	0.000223	0.00587	CcSEcCtD
Liothyronine—ALB—adrenal gland—breast cancer	0.000222	0.0073	CbGeAlD
Liothyronine—Acute coronary syndrome—Gemcitabine—breast cancer	0.00022	0.0058	CcSEcCtD
Liothyronine—Hypertension—Tamoxifen—breast cancer	0.000219	0.00578	CcSEcCtD
Liothyronine—Myocardial infarction—Gemcitabine—breast cancer	0.000219	0.00577	CcSEcCtD
Liothyronine—Acute coronary syndrome—Fluorouracil—breast cancer	0.000216	0.0057	CcSEcCtD
Liothyronine—Myocardial infarction—Fluorouracil—breast cancer	0.000215	0.00567	CcSEcCtD
Liothyronine—SLC7A5—lymph node—breast cancer	0.000214	0.00704	CbGeAlD
Liothyronine—Arrhythmia—Thiotepa—breast cancer	0.000213	0.00561	CcSEcCtD
Liothyronine—Hypertension—Goserelin—breast cancer	0.000209	0.00552	CcSEcCtD
Liothyronine—Tachycardia—Melphalan—breast cancer	0.000198	0.00522	CcSEcCtD
Liothyronine—SLCO1A2—endocrine gland—breast cancer	0.000193	0.00637	CbGeAlD
Liothyronine—Tachycardia—Goserelin—breast cancer	0.000193	0.00509	CcSEcCtD
Liothyronine—Hypotension—Melphalan—breast cancer	0.000189	0.005	CcSEcCtD
Liothyronine—Hypertension—Vinorelbine—breast cancer	0.000187	0.00494	CcSEcCtD
Liothyronine—SLCO4A1—lymph node—breast cancer	0.000187	0.00615	CbGeAlD
Liothyronine—Hypotension—Goserelin—breast cancer	0.000185	0.00487	CcSEcCtD
Liothyronine—Acute coronary syndrome—Paclitaxel—breast cancer	0.000184	0.00486	CcSEcCtD
Liothyronine—Body temperature increased—Chlorambucil—breast cancer	0.000184	0.00485	CcSEcCtD
Liothyronine—Arrhythmia—Irinotecan—breast cancer	0.000184	0.00484	CcSEcCtD
Liothyronine—Arrhythmia—Mitoxantrone—breast cancer	0.000184	0.00484	CcSEcCtD
Liothyronine—Myocardial infarction—Paclitaxel—breast cancer	0.000183	0.00483	CcSEcCtD
Liothyronine—Hypertension—Thiotepa—breast cancer	0.000179	0.00472	CcSEcCtD
Liothyronine—Arrhythmia—Gemcitabine—breast cancer	0.000179	0.00472	CcSEcCtD
Liothyronine—Arrhythmia—Fluorouracil—breast cancer	0.000176	0.00464	CcSEcCtD
Liothyronine—Angina pectoris—Docetaxel—breast cancer	0.000173	0.00456	CcSEcCtD
Liothyronine—Tachycardia—Vinorelbine—breast cancer	0.000173	0.00456	CcSEcCtD
Liothyronine—Angina pectoris—Capecitabine—breast cancer	0.000168	0.00442	CcSEcCtD
Liothyronine—Hypotension—Vinorelbine—breast cancer	0.000166	0.00437	CcSEcCtD
Liothyronine—Tachycardia—Thiotepa—breast cancer	0.000165	0.00435	CcSEcCtD
Liothyronine—SLC16A10—lymph node—breast cancer	0.000164	0.00539	CbGeAlD
Liothyronine—Phlebitis—Epirubicin—breast cancer	0.000161	0.00424	CcSEcCtD
Liothyronine—Body temperature increased—Goserelin—breast cancer	0.000156	0.00412	CcSEcCtD
Liothyronine—Acute coronary syndrome—Docetaxel—breast cancer	0.000156	0.00412	CcSEcCtD
Liothyronine—Myocardial infarction—Docetaxel—breast cancer	0.000155	0.00409	CcSEcCtD
Liothyronine—Hypertension—Irinotecan—breast cancer	0.000155	0.00408	CcSEcCtD
Liothyronine—Hypertension—Mitoxantrone—breast cancer	0.000155	0.00408	CcSEcCtD
Liothyronine—Cardiac failure congestive—Epirubicin—breast cancer	0.000153	0.00403	CcSEcCtD
Liothyronine—Acute coronary syndrome—Capecitabine—breast cancer	0.000151	0.00399	CcSEcCtD
Liothyronine—Hypertension—Gemcitabine—breast cancer	0.000151	0.00397	CcSEcCtD
Liothyronine—Myocardial infarction—Capecitabine—breast cancer	0.00015	0.00396	CcSEcCtD
Liothyronine—Arrhythmia—Paclitaxel—breast cancer	0.00015	0.00395	CcSEcCtD
Liothyronine—Phlebitis—Doxorubicin—breast cancer	0.000149	0.00393	CcSEcCtD
Liothyronine—Tachycardia—Mitoxantrone—breast cancer	0.000143	0.00376	CcSEcCtD
Liothyronine—Cardiac failure congestive—Doxorubicin—breast cancer	0.000141	0.00373	CcSEcCtD
Liothyronine—Body temperature increased—Vinorelbine—breast cancer	0.00014	0.00369	CcSEcCtD
Liothyronine—Tachycardia—Fluorouracil—breast cancer	0.000137	0.0036	CcSEcCtD
Liothyronine—Hypotension—Irinotecan—breast cancer	0.000137	0.0036	CcSEcCtD
Liothyronine—Hypotension—Mitoxantrone—breast cancer	0.000137	0.0036	CcSEcCtD
Liothyronine—Body temperature increased—Thiotepa—breast cancer	0.000134	0.00353	CcSEcCtD
Liothyronine—Hypotension—Gemcitabine—breast cancer	0.000133	0.00351	CcSEcCtD
Liothyronine—ALB—lymph node—breast cancer	0.000133	0.00438	CbGeAlD
Liothyronine—Hypotension—Fluorouracil—breast cancer	0.000131	0.00345	CcSEcCtD
Liothyronine—Arrhythmia—Docetaxel—breast cancer	0.000127	0.00335	CcSEcCtD
Liothyronine—ABCB1—embryo—breast cancer	0.000126	0.00416	CbGeAlD
Liothyronine—Hypertension—Paclitaxel—breast cancer	0.000126	0.00332	CcSEcCtD
Liothyronine—Arrhythmia—Capecitabine—breast cancer	0.000123	0.00324	CcSEcCtD
Liothyronine—Angina pectoris—Epirubicin—breast cancer	0.000117	0.00308	CcSEcCtD
Liothyronine—Tachycardia—Paclitaxel—breast cancer	0.000116	0.00307	CcSEcCtD
Liothyronine—Body temperature increased—Irinotecan—breast cancer	0.000116	0.00305	CcSEcCtD
Liothyronine—Body temperature increased—Mitoxantrone—breast cancer	0.000116	0.00305	CcSEcCtD
Liothyronine—Body temperature increased—Gemcitabine—breast cancer	0.000113	0.00297	CcSEcCtD
Liothyronine—Hypotension—Paclitaxel—breast cancer	0.000111	0.00294	CcSEcCtD
Liothyronine—Body temperature increased—Fluorouracil—breast cancer	0.000111	0.00292	CcSEcCtD
Liothyronine—Angina pectoris—Doxorubicin—breast cancer	0.000108	0.00285	CcSEcCtD
Liothyronine—Hypertension—Docetaxel—breast cancer	0.000107	0.00282	CcSEcCtD
Liothyronine—Hypertension—Capecitabine—breast cancer	0.000103	0.00273	CcSEcCtD
Liothyronine—ABCB1—epithelium—breast cancer	0.000103	0.00339	CbGeAlD
Liothyronine—Tachycardia—Docetaxel—breast cancer	9.86e-05	0.0026	CcSEcCtD
Liothyronine—Tachycardia—Capecitabine—breast cancer	9.54e-05	0.00252	CcSEcCtD
Liothyronine—Hypotension—Docetaxel—breast cancer	9.44e-05	0.00249	CcSEcCtD
Liothyronine—Body temperature increased—Paclitaxel—breast cancer	9.42e-05	0.00248	CcSEcCtD
Liothyronine—ABCB1—endometrium—breast cancer	9.25e-05	0.00304	CbGeAlD
Liothyronine—Hypotension—Capecitabine—breast cancer	9.14e-05	0.00241	CcSEcCtD
Liothyronine—Arrhythmia—Epirubicin—breast cancer	8.57e-05	0.00226	CcSEcCtD
Liothyronine—ABCB1—uterus—breast cancer	8.52e-05	0.0028	CbGeAlD
Liothyronine—ABCB1—pituitary gland—breast cancer	8.37e-05	0.00275	CbGeAlD
Liothyronine—ABCB1—adipose tissue—breast cancer	8.33e-05	0.00274	CbGeAlD
Liothyronine—Body temperature increased—Docetaxel—breast cancer	7.98e-05	0.00211	CcSEcCtD
Liothyronine—Arrhythmia—Doxorubicin—breast cancer	7.93e-05	0.00209	CcSEcCtD
Liothyronine—Body temperature increased—Capecitabine—breast cancer	7.73e-05	0.00204	CcSEcCtD
Liothyronine—ABCB1—female reproductive system—breast cancer	7.66e-05	0.00252	CbGeAlD
Liothyronine—ABCB1—adrenal gland—breast cancer	7.47e-05	0.00246	CbGeAlD
Liothyronine—ABCB1—bone marrow—breast cancer	7.23e-05	0.00238	CbGeAlD
Liothyronine—Hypertension—Epirubicin—breast cancer	7.21e-05	0.0019	CcSEcCtD
Liothyronine—ABCB1—female gonad—breast cancer	6.97e-05	0.00229	CbGeAlD
Liothyronine—Hypotension—Methotrexate—breast cancer	6.8e-05	0.00179	CcSEcCtD
Liothyronine—Hypertension—Doxorubicin—breast cancer	6.67e-05	0.00176	CcSEcCtD
Liothyronine—Tachycardia—Epirubicin—breast cancer	6.65e-05	0.00175	CcSEcCtD
Liothyronine—ABCB1—endocrine gland—breast cancer	6.48e-05	0.00213	CbGeAlD
Liothyronine—Hypotension—Epirubicin—breast cancer	6.37e-05	0.00168	CcSEcCtD
Liothyronine—Levothyroxine—CYP3A4—breast cancer	6.27e-05	0.0218	CrCbGaD
Liothyronine—Tachycardia—Doxorubicin—breast cancer	6.15e-05	0.00162	CcSEcCtD
Liothyronine—Hypotension—Doxorubicin—breast cancer	5.89e-05	0.00155	CcSEcCtD
Liothyronine—Body temperature increased—Methotrexate—breast cancer	5.75e-05	0.00152	CcSEcCtD
Liothyronine—Levothyroxine—ALB—breast cancer	5.47e-05	0.019	CrCbGaD
Liothyronine—Body temperature increased—Epirubicin—breast cancer	5.39e-05	0.00142	CcSEcCtD
Liothyronine—Liotrix—ALB—breast cancer	5.34e-05	0.0185	CrCbGaD
Liothyronine—Levothyroxine—ABCB1—breast cancer	5.22e-05	0.0181	CrCbGaD
Liothyronine—Liotrix—ABCB1—breast cancer	5.09e-05	0.0177	CrCbGaD
Liothyronine—Body temperature increased—Doxorubicin—breast cancer	4.98e-05	0.00131	CcSEcCtD
Liothyronine—ABCB1—lymph node—breast cancer	4.48e-05	0.00148	CbGeAlD
Liothyronine—L-DOPA—CYP2D6—breast cancer	3.84e-05	0.0133	CrCbGaD
Liothyronine—ALB—Metabolism—IDH1—breast cancer	2.5e-06	3.49e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—GSTA1—breast cancer	2.5e-06	3.49e-05	CbGpPWpGaD
Liothyronine—TTR—Disease—TGFB1—breast cancer	2.5e-06	3.49e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—PLA2G4A—breast cancer	2.5e-06	3.49e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—NCOR1—breast cancer	2.5e-06	3.49e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—GSTM1—breast cancer	2.5e-06	3.49e-05	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—PTEN—breast cancer	2.49e-06	3.49e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—RELA—breast cancer	2.49e-06	3.48e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.47e-06	3.46e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—ERBB2—breast cancer	2.47e-06	3.46e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—NAT2—breast cancer	2.47e-06	3.45e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—PPARGC1B—breast cancer	2.46e-06	3.45e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—CAV1—breast cancer	2.45e-06	3.43e-05	CbGpPWpGaD
Liothyronine—ALB—Platelet activation, signaling and aggregation—MAPK3—breast cancer	2.45e-06	3.43e-05	CbGpPWpGaD
Liothyronine—ABCB1—Transmembrane transport of small molecules—HMOX1—breast cancer	2.45e-06	3.43e-05	CbGpPWpGaD
Liothyronine—TTR—Disease—EGFR—breast cancer	2.45e-06	3.42e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—PIK3CB—breast cancer	2.44e-06	3.41e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—MTOR—breast cancer	2.44e-06	3.41e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	2.41e-06	3.38e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—GPX1—breast cancer	2.39e-06	3.34e-05	CbGpPWpGaD
Liothyronine—ALB—Platelet activation, signaling and aggregation—TGFB1—breast cancer	2.38e-06	3.33e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—CYP1A1—breast cancer	2.37e-06	3.31e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—PIK3CG—breast cancer	2.36e-06	3.3e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.36e-06	3.3e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	2.35e-06	3.28e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—ERCC2—breast cancer	2.35e-06	3.28e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—CXCL8—breast cancer	2.35e-06	3.28e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	2.34e-06	3.28e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—FN1—breast cancer	2.33e-06	3.26e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—COMT—breast cancer	2.33e-06	3.26e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GSTA4—breast cancer	2.33e-06	3.26e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—CA9—breast cancer	2.33e-06	3.26e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—GSTP1—breast cancer	2.32e-06	3.25e-05	CbGpPWpGaD
Liothyronine—TTR—Disease—KRAS—breast cancer	2.31e-06	3.24e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—NOS2—breast cancer	2.31e-06	3.23e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	2.3e-06	3.21e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—HMOX1—breast cancer	2.29e-06	3.2e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—CDKN1B—breast cancer	2.29e-06	3.2e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—ITPR1—breast cancer	2.29e-06	3.2e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GSTA2—breast cancer	2.27e-06	3.17e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GPX2—breast cancer	2.27e-06	3.17e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—CASP3—breast cancer	2.25e-06	3.14e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—IL2—breast cancer	2.24e-06	3.14e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—SULT1A1—breast cancer	2.24e-06	3.13e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GPX4—breast cancer	2.24e-06	3.13e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—PIK3CG—breast cancer	2.23e-06	3.12e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—CAV1—breast cancer	2.23e-06	3.12e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—EGF—breast cancer	2.21e-06	3.09e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—MTHFR—breast cancer	2.21e-06	3.09e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—ABCB1—breast cancer	2.2e-06	3.08e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GSTA1—breast cancer	2.19e-06	3.06e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—IDH1—breast cancer	2.19e-06	3.06e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	2.19e-06	3.06e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—CCND1—breast cancer	2.19e-06	3.06e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—JUN—breast cancer	2.18e-06	3.05e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	2.17e-06	3.03e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—MED12—breast cancer	2.17e-06	3.03e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—DPYD—breast cancer	2.17e-06	3.03e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—CTNNB1—breast cancer	2.16e-06	3.03e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—NAT2—breast cancer	2.16e-06	3.03e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—TYMS—breast cancer	2.16e-06	3.02e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—GSTM1—breast cancer	2.13e-06	2.99e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—PLA2G4A—breast cancer	2.13e-06	2.99e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—NCOR1—breast cancer	2.13e-06	2.99e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—ALDOA—breast cancer	2.13e-06	2.98e-05	CbGpPWpGaD
Liothyronine—TTR—Disease—PIK3CA—breast cancer	2.13e-06	2.97e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—MMP9—breast cancer	2.12e-06	2.97e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—CDKN1A—breast cancer	2.11e-06	2.96e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—PTEN—breast cancer	2.11e-06	2.95e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—PIK3CD—breast cancer	2.07e-06	2.9e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—NCOA3—breast cancer	2.07e-06	2.89e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—MAPK8—breast cancer	2.06e-06	2.89e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—SLC2A2—breast cancer	2.05e-06	2.87e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—ALB—breast cancer	2.05e-06	2.86e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—IGF1—breast cancer	2.05e-06	2.86e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—GPX1—breast cancer	2.04e-06	2.86e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—AKT2—breast cancer	2.04e-06	2.86e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—CAV1—breast cancer	2.04e-06	2.85e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	2.03e-06	2.84e-05	CbGpPWpGaD
Liothyronine—ALB—Platelet activation, signaling and aggregation—PIK3CA—breast cancer	2.02e-06	2.83e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—CYP1A1—breast cancer	2.02e-06	2.83e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—ABCG2—breast cancer	2.01e-06	2.82e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—MTR—breast cancer	2.01e-06	2.82e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—CPT1A—breast cancer	2.01e-06	2.82e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—ERCC2—breast cancer	2.01e-06	2.81e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	1.99e-06	2.79e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—HPGDS—breast cancer	1.97e-06	2.76e-05	CbGpPWpGaD
Liothyronine—TTR—Disease—HRAS—breast cancer	1.97e-06	2.75e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—PIK3CD—breast cancer	1.96e-06	2.75e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—HBA1—breast cancer	1.96e-06	2.74e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—NOS3—breast cancer	1.96e-06	2.74e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—SRC—breast cancer	1.96e-06	2.74e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.94e-06	2.72e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—SERPINE1—breast cancer	1.94e-06	2.72e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	1.93e-06	2.7e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—ACHE—breast cancer	1.91e-06	2.68e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—GSTT1—breast cancer	1.91e-06	2.68e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—VEGFA—breast cancer	1.91e-06	2.66e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—MED12—breast cancer	1.9e-06	2.65e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—DPYD—breast cancer	1.9e-06	2.65e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—MTHFR—breast cancer	1.89e-06	2.64e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—STAT3—breast cancer	1.89e-06	2.64e-05	CbGpPWpGaD
Liothyronine—TTR—Disease—IL6—breast cancer	1.88e-06	2.63e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—ALDOA—breast cancer	1.87e-06	2.61e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—NOS3—breast cancer	1.85e-06	2.59e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—PIK3CG—breast cancer	1.85e-06	2.59e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—NCOA3—breast cancer	1.81e-06	2.54e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—CYP17A1—breast cancer	1.81e-06	2.54e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—PIK3CB—breast cancer	1.81e-06	2.53e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—MAPK3—breast cancer	1.8e-06	2.52e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—SLC2A2—breast cancer	1.8e-06	2.52e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—ENO1—breast cancer	1.79e-06	2.51e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—PTGS1—breast cancer	1.79e-06	2.51e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—PTGS2—breast cancer	1.79e-06	2.51e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.79e-06	2.5e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—CPT1A—breast cancer	1.76e-06	2.47e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—ABCG2—breast cancer	1.76e-06	2.47e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—MTR—breast cancer	1.76e-06	2.47e-05	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—PIK3CA—breast cancer	1.76e-06	2.46e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—CYP2D6—breast cancer	1.76e-06	2.46e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—RAF1—breast cancer	1.75e-06	2.45e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—MYC—breast cancer	1.75e-06	2.45e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—TGFB1—breast cancer	1.75e-06	2.45e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—CAV1—breast cancer	1.74e-06	2.43e-05	CbGpPWpGaD
Liothyronine—TTR—Disease—AKT1—breast cancer	1.74e-06	2.43e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—HPGDS—breast cancer	1.73e-06	2.42e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—NCOA2—breast cancer	1.73e-06	2.42e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—HBA1—breast cancer	1.72e-06	2.4e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—EGFR—breast cancer	1.71e-06	2.4e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—PIK3CB—breast cancer	1.71e-06	2.39e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GSTT1—breast cancer	1.68e-06	2.35e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—ACHE—breast cancer	1.68e-06	2.35e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—FASN—breast cancer	1.68e-06	2.34e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—BCHE—breast cancer	1.67e-06	2.33e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.66e-06	2.33e-05	CbGpPWpGaD
Liothyronine—ALB—Platelet activation, signaling and aggregation—AKT1—breast cancer	1.65e-06	2.31e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—SLC5A5—breast cancer	1.65e-06	2.3e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—PIK3CD—breast cancer	1.63e-06	2.28e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	1.63e-06	2.28e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—KRAS—breast cancer	1.62e-06	2.27e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—ALB—breast cancer	1.61e-06	2.25e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—SLC2A1—breast cancer	1.59e-06	2.23e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—NQO1—breast cancer	1.59e-06	2.23e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—CYP17A1—breast cancer	1.59e-06	2.22e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—PIK3CG—breast cancer	1.59e-06	2.22e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—ENO1—breast cancer	1.57e-06	2.2e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—PTGS1—breast cancer	1.57e-06	2.2e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—IL2—breast cancer	1.57e-06	2.2e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—PTEN—breast cancer	1.56e-06	2.18e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.56e-06	2.18e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—CYP3A4—breast cancer	1.55e-06	2.17e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.54e-06	2.16e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—CYP2D6—breast cancer	1.54e-06	2.16e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—NOS3—breast cancer	1.54e-06	2.15e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—CYP1B1—breast cancer	1.53e-06	2.13e-05	CbGpPWpGaD
Liothyronine—ALB—Transmembrane transport of small molecules—RAF1—breast cancer	1.52e-06	2.12e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—NCOA2—breast cancer	1.51e-06	2.12e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—HSP90AA1—breast cancer	1.5e-06	2.09e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—PIK3CA—breast cancer	1.49e-06	2.08e-05	CbGpPWpGaD
Liothyronine—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	1.47e-06	2.06e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—FASN—breast cancer	1.47e-06	2.05e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—BCHE—breast cancer	1.46e-06	2.04e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—NCOA1—breast cancer	1.46e-06	2.04e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—SLC5A5—breast cancer	1.44e-06	2.02e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—TP53—breast cancer	1.44e-06	2.01e-05	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—AKT1—breast cancer	1.44e-06	2.01e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—STK11—breast cancer	1.43e-06	2.01e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—CYP19A1—breast cancer	1.43e-06	2.01e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—PIK3CB—breast cancer	1.42e-06	1.99e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—PTGS2—breast cancer	1.41e-06	1.97e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—SLC2A1—breast cancer	1.39e-06	1.95e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—NQO1—breast cancer	1.39e-06	1.95e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—PIK3CD—breast cancer	1.39e-06	1.95e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—HRAS—breast cancer	1.38e-06	1.93e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—ALB—breast cancer	1.38e-06	1.92e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—SRC—breast cancer	1.37e-06	1.92e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—CYP3A4—breast cancer	1.36e-06	1.9e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.35e-06	1.88e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—CYP1B1—breast cancer	1.34e-06	1.87e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—VEGFA—breast cancer	1.34e-06	1.87e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—COMT—breast cancer	1.33e-06	1.87e-05	CbGpPWpGaD
Liothyronine—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	1.33e-06	1.86e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—GSTP1—breast cancer	1.33e-06	1.86e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—IL6—breast cancer	1.32e-06	1.84e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—NOS3—breast cancer	1.32e-06	1.84e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—HSP90AA1—breast cancer	1.31e-06	1.83e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—HMOX1—breast cancer	1.31e-06	1.83e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—ITPR1—breast cancer	1.31e-06	1.83e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—NCOA1—breast cancer	1.28e-06	1.78e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—MAPK3—breast cancer	1.26e-06	1.77e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—STK11—breast cancer	1.26e-06	1.76e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—CYP19A1—breast cancer	1.26e-06	1.76e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—ABCB1—breast cancer	1.26e-06	1.76e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—TYMS—breast cancer	1.23e-06	1.73e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—PTEN—breast cancer	1.23e-06	1.72e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—TGFB1—breast cancer	1.23e-06	1.72e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—NCOR1—breast cancer	1.22e-06	1.71e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—GSTM1—breast cancer	1.22e-06	1.71e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—PLA2G4A—breast cancer	1.22e-06	1.71e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—AKT1—breast cancer	1.22e-06	1.7e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—PIK3CB—breast cancer	1.21e-06	1.7e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—PTGS2—breast cancer	1.2e-06	1.68e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—COMT—breast cancer	1.17e-06	1.63e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—GPX1—breast cancer	1.17e-06	1.63e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GSTP1—breast cancer	1.16e-06	1.63e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—CYP1A1—breast cancer	1.16e-06	1.62e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—HMOX1—breast cancer	1.15e-06	1.6e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—ERCC2—breast cancer	1.15e-06	1.6e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—ITPR1—breast cancer	1.14e-06	1.6e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—KRAS—breast cancer	1.14e-06	1.59e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—PIK3CA—breast cancer	1.1e-06	1.54e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—TYMS—breast cancer	1.08e-06	1.51e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—MTHFR—breast cancer	1.08e-06	1.51e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GSTM1—breast cancer	1.07e-06	1.49e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—PLA2G4A—breast cancer	1.07e-06	1.49e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—NCOR1—breast cancer	1.07e-06	1.49e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—PTEN—breast cancer	1.05e-06	1.47e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—PIK3CA—breast cancer	1.04e-06	1.46e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GPX1—breast cancer	1.02e-06	1.43e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—CYP1A1—breast cancer	1.01e-06	1.42e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—TP53—breast cancer	1.01e-06	1.41e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—ERCC2—breast cancer	1e-06	1.41e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—CAV1—breast cancer	9.94e-07	1.39e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—HRAS—breast cancer	9.65e-07	1.35e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	9.5e-07	1.33e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—MTHFR—breast cancer	9.45e-07	1.32e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—PIK3CG—breast cancer	9.06e-07	1.27e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—AKT1—breast cancer	9e-07	1.26e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—CAV1—breast cancer	8.71e-07	1.22e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—PIK3CA—breast cancer	8.66e-07	1.21e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—AKT1—breast cancer	8.52e-07	1.19e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—PIK3CD—breast cancer	7.96e-07	1.11e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—PIK3CG—breast cancer	7.94e-07	1.11e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—NOS3—breast cancer	7.52e-07	1.05e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—PIK3CA—breast cancer	7.4e-07	1.04e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—AKT1—breast cancer	7.07e-07	9.89e-06	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—PIK3CD—breast cancer	6.98e-07	9.76e-06	CbGpPWpGaD
Liothyronine—ALB—Metabolism—PIK3CB—breast cancer	6.94e-07	9.71e-06	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—ALB—breast cancer	6.89e-07	9.63e-06	CbGpPWpGaD
Liothyronine—ALB—Metabolism—PTGS2—breast cancer	6.88e-07	9.62e-06	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—NOS3—breast cancer	6.59e-07	9.21e-06	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—PIK3CB—breast cancer	6.08e-07	8.5e-06	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—AKT1—breast cancer	6.05e-07	8.46e-06	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—PTGS2—breast cancer	6.03e-07	8.43e-06	CbGpPWpGaD
Liothyronine—ALB—Metabolism—PTEN—breast cancer	6e-07	8.39e-06	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—PTEN—breast cancer	5.25e-07	7.35e-06	CbGpPWpGaD
Liothyronine—ALB—Metabolism—PIK3CA—breast cancer	4.23e-07	5.92e-06	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—PIK3CA—breast cancer	3.71e-07	5.18e-06	CbGpPWpGaD
Liothyronine—ALB—Metabolism—AKT1—breast cancer	3.46e-07	4.83e-06	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—AKT1—breast cancer	3.03e-07	4.24e-06	CbGpPWpGaD
